Article
Hormonal prevention of breast cancer.
Annales d'endocrinologie - 1 Jul 2014
Thomin Anne, Friszer Stéphanie, Fajac Anne, Daraï Émile, Chabbert-Buffet Nathalie
Abstract excerpt
Breast cancer prevention can be provided by using SERMs or aromatase inhibitors depending on the ovarian status, with a global risk reduction of 50 to 60%. Prophylactic annexectomy offered to reduce ovarian risk in BRCA mutation carriers also lowers breast cancer risk by 50%. Main side effects in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
